07971459383

Change Language

KETHAN PHARMA DISTRIBUTORS
GST : 36ABMPO2384G1ZD

Our Products

Pharmaceutical Tablets

Pharmaceutical Injection

Pharmaceutical Capsules

Anti Cancer Injection

Mircera 50 Mcg Injection

Therapy Lotion

Cardiovascular Injection

Recombinant Tissue Plasminogen Activator For Injection 20 Mg Kit

Pharmaceutical Cream

Mouth Freshener Spray

X-Wet Saliva Supplement Mouth Spray

Oral Suspension

Megestrol Acetate Oral Suspension USP

Pharmaceutical Syrup

Curcuage Liquid

Pegadria 20 Pegylated Liposomal Doxorubicin Hydrochloride Injection

Name: Pegadria 20 Pegylated Liposomal Doxorubicin Hydrochloride Injection
Brand: KETHAN PHARMA DISTRIBUTORS
Price: 2000 INR
Availability: InStock

Price 2000 INR/ Unit

Get a Price/Quote

MOQ : 8 Units

Pegadria 20 Pegylated Liposomal Doxorubicin Hydrochloride Injection Specification

Indication
Cancer Chemotherapy

Dosage Form
Injection

Salt Composition
Doxorubicin (Pegylated Liposomal) 20mg

Feature
Pegylated; Liposomal delivery system

Ingredients
Doxorubicin Hydrochloride Pegylated Liposomal

Application
Oncology

Physical Color/Texture
Sterile Red Solution

Fermentation Smell
Odorless

Storage Instructions
Store below 25C

Shelf Life
24 Months

PCD Pharma
Available

Treatment Area
Oncology

Packaging Size
10ml

Diluent
Sterile water

Color
Red

Prescription Status
Prescription only

Route of Administration
IV infusion

Single Dose Vial
Yes

Liposomal Type
Pegylated

Pegadria 20 Pegylated Liposomal Doxorubicin Hydrochloride Injection Trade Information

Minimum Order Quantity
8 Units

Payment Terms
Cash in Advance (CID)

Supply Ability
1000 Units Per Month

Delivery Time
7 Days

Main Domestic Market
All India

Pegadria 20 Pegylated Liposomal Doxorubicin Hydrochloride Injection About

Pegadria 20 Pegylated Liposomal Doxorubicin Hydrochloride Injection is a featured therapy in modern oncology care, expertly formulated for cancer chemotherapy. This world-class, single-dose vial contains 20mg of pegylated liposomal doxorubicin hydrochloride in a sterile, red solution, ensuring matchless efficacy and safety. Designed for IV infusion, each vial is accompanied by sterile water for dilution. The pegylated liposomal delivery system grants extraordinary stability, improving patient outcomes. Procure this innovative injection exclusively through prescription-a new standard in cancer treatment. Certified for export, Pegadria 20 is available to suppliers, traders, and PCD pharma partners across India.

Comprehensive Oncology Solution with Exceptional Features

Pegadria 20 is primarily applied in oncology, targeting a broad spectrum of cancer indications. Notable for its pegylated, liposomal delivery system, it ensures precise and sustained drug release. The sterile red solution is administered intravenously for systemic treatment on the internal body surfaces. This matchless formulation minimizes side effects compared to traditional therapies, making it an extraordinary choice for oncologists seeking advanced, patient-centric cancer remedies.

Payment Terms, Supply Assurance, and Certifications

Pegadria 20 is available at a competitive asking price, with flexible payment options tailored for exporters, suppliers, and traders. The product is backed by certifications assuring quality and compliance. With robust supply ability, timely fulfillment is guaranteed, complemented by express shipping and secure transportation services. Each transaction is streamlined to ensure customer satisfaction and regulatory confidence. Count on certified quality and reliable procurement for your oncology needs.

FAQ's of Pegadria 20 Pegylated Liposomal Doxorubicin Hydrochloride Injection:

Q: How is Pegadria 20 administered to patients?

A: Pegadria 20 is administered through intravenous (IV) infusion, using the sterile red solution provided in the single-dose vial, as prescribed by an oncology specialist.

Q: What makes Pegadria 20 unique compared to other formulations?

A: The injection features a matchless pegylated liposomal delivery system, ensuring targeted release and reduced side effects, setting it apart from conventional doxorubicin therapies.

Q: When should Pegadria 20 be procured for cancer treatment?

A: Pegadria 20 should be procured and used strictly under the recommendation and prescription of a qualified oncologist, tailored to the specific chemotherapy regimen.

Q: Where can Pegadria 20 be obtained in India?

A: Pegadria 20 is available through authorized exporters, suppliers, traders, and PCD pharma partners across India, subject to prescription only.

Q: What is the process for purchasing Pegadria 20 for institutional use?

A: Institutions can contact certified suppliers, provide legal and regulatory documentation, finalize payment terms, and arrange for express shipping with assured transportation.

Q: What are the benefits of the pegylated liposomal delivery system in Pegadria 20?

A: The pegylated liposomal delivery ensures prolonged circulation, enhanced drug targeting to cancer cells, and significantly lowers the risk of adverse effects for patients.